-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today (March 17), the official website of NMPA showed that Puli Pharmaceutical's desloratadine dispersible tablets and desloratadine dry suspension passed the consistency evaluation.
Desloratadine is a non-sedating long-acting tricyclic antihistamine and the active metabolite of loratadine.
According to data from Minai.
Brand pattern of the terminal desloratadine in China's public medical institutions in 2019
Source: Mi Nei.
The desloratadine products currently on the market in China include desloratadine tablets, desloratadine dispersible tablets, desloratadine dry suspension, desloratadine capsules, desloratadine syrup and Deloratadine oral solution.
The oral constant-release dosage form of desloratadine has been included in the third batch of centralized procurement.
Source: Mi Neiwang database, NMPA